APONTIS PHARMA launches two new single pills – medium-term revenue potential of EUR 8.2 million

Monheim am Rhein, 25 May 2022. APONTIS PHARMA AG (Ticker APPH / ISIN DE000A3CMGM5), a leading pharmaceutical company specializing in Single Pills in the German market, is fully on track to meet its targets. Today, the Single Pill Company announces the launch of two of its compounds in the month of May. With the single pills Tonotec Lipid and AmloAtor, APONTIS PHARMA is addressing the large group of patients with high blood pressure and lipid metabolism disorders in Germany and has already been able to realize two of the at least three planned market launches in the financial year 2022 . For the two single pills, this results in a total potential patient group of around 750,000 people. APONTIS PHARMA anticipates a medium-term revenue potential for Tonotec Lipid of EUR 5.0 million and for AmloAtor of EUR 3.2 million.

In Germany alone, the group of diagnosed hypertension patients comprises more than 22 million people. Many of these patients suffer from high cholesterol levels and a disorder of the lipid metabolism. It can be assumed that at least 750,000 patients are affected by both disorders together. High blood pressure and dyslipidemia alone increase the risk of consequences for the cardiovascular system. If both diseases occur simultaneously, the risk increases by a multiple. To achieve their therapeutic goals, these patients are dependent on a combination of different active ingredients, which means that they have to take a large number of individual medications. As the number of pills increases, so does the risk that they will not be taken reliably – which in turn increases the risk of coronary heart disease, heart attack and stroke. With the combination products Tonotec Lipid and AmloAtor, APONTIS PHARMA supports patients’ therapy in a far more efficient way. Tonotec Lipid combines the active ingredients Ramipril, Amlodipine and Atorvastatin in a single pill. In the case of AmloAtor, it is Amlodipine and Atorvastatin.

The efficient mode of action of Single Pill therapy was scientifically confirmed by the “START” study and published in the peer-reviewed publications “Integrated Blood Pressure Control” and “Journal of Comparative Effectiveness Research”, among others. In total, data from 59,336 patients were included in the evaluation of the “START” study, which showed, among other results, significantly higher treatment adherence, a lower number of GP visits and lower total costs per patient.

“We are pleased with these milestones achieved in two respects. On the one hand, we are getting much closer to our goal of at least three marketed compounds in the very first half of 2022. On the other hand, we are expanding our product pipeline and can offer the large and steadily growing number of hypertension patients a more effective and cost-saving therapy. Our task now is to consolidate this success in the coming weeks and months,” says Karlheinz Gast, Chief Executive Officer of APONTIS PHARMA AG.
APONTIS PHARMA AG is a leading pharmaceutical company specializing in Single Pills in Germany. Single Pills combine two to three generic active ingredients in a single dosage form. APONTIS PHARMA develops, promotes and sells a broad portfolio of Single Pills and other pharmaceutical products, with a special focus on cardiovascular diseases. Since 2013, APONTIS successfully launched several Single Pill products alone for cardiovascular indications such as hypertension, hyperlipidemia and secondary prevention. With its headquarters in Monheim am Rhein, APONTIS PHARMA is located in one of Europe’s leading pharmaceutical and chemical region. From here, the company maintains a broad network with research-based pharmaceutical companies and a customer target group of approx. 23,000 physicians in Germany. For additional information about APONTIS PHARMA, please visit www.apontis-pharma.de.
Investor Relations
T: +49 2173 89 55 4900
F: +49 2173 89 55 1521
Alfred-Nobel-Str. 10
40789 Monheim am Rhein
CROSS ALLIANCE communication GmbH
Sven Pauly
T: +49 89 125 09 0330

Linda Lenz

"Creativity and perfection are not mutually exclusive, but complementary."

IR Consultant at CROSS ALLIANCE since 2021.
Linda Lenz’s core competencies are public and influencer relations as well as project management.
With a a M.Sc. degree in Strategic Communication and PR and a B.A. in English Studies and Communication and Media Studies, she is fully committed to her clients because she always insists on doing the job right.
4 years of experience in Public Relations and Influencer Relations expertise in the Automotive and Energy Special Supporter ESG industries.

Jens Jüttner

"Designing a customised communication strategy for clients is what drives me. Their success is my reward."

Jens Jüttner has extensive experience in news and business journalism across all presentation formats and channels. As an investor relations consultant, he devotes his energies to the regular communications of listed companies and also provides support with their media relations activities.

Senior Consultant at CROSS ALLIANCE since 2018
BA in Journalism / Banking Officer
Five years as a member of the editorial team of business and investor magazine FOCUS-MONEY
Three years as Head of Department for “Week”
Extensive experience in writing advertorials
Shortlisted for the Alternative Media Prize 2013
Social Media Manager (Chambers of Industry and Commerce) – final project: Development of a hybrid social media campaign for LinkedIn and Twitter for an IR and media agency

T: +49 89 125 09 03 32

Markus Horntrich

"My maxim to ensure optimum performance on all your communications issues: Get up early, give it your all and work hard."

Markus Horntrich is a stock market enthusiast and, as a former editor-in-chief, has extensive experience in financial journalism and a broad network, which he uses as a basis for all aspects of PR/IR communication.

Economics graduate
Self-employed PR/IR consultant and Senior Consultant at CROSS ALLIANCE
19 years at investor magazine DER AKTIONÄR
8 years as editor-in-chief at DER AKTIONÄR

T: +49 89 125 09 03 30
M: +49 170 321 42 26

Michael Lang

"As a former editor-in-chief and full-blooded journalist, a matter particularly close to my heart is ensuring that our clients get noticed in just the right way in the media."

As an experienced business journalist, Michael Lang uses his extensive network in the financial community to give clients the best media relations.

Partner at CROSS ALLIANCE since 2013
Self-employed professional in investor relations since 2010
Head of IR at IBS AG (Prime Standard) for four years
Ten years as a member of the editorial team of financial magazine DER AKTIONÄR (“2010 award for investor magazine of the year”), acting as editor-in-chief and deputy editor-in-chief, in both positions for three years
15 years of experience in financial journalism
Degree in Business Mathematics, Bayreuth University

T: +49 89 125 09 03 34

Susan Hoffmeister

"I support every company with communication just as I do my own. That's my biggest motivation."

Managing Director Susan Hoffmeister supports listed companies with their investor relations and ESG.

Founder & Managing Director of CROSS ALLIANCE communication GmbH
Degree in Business Administration, BA in Finance & Accounting, MBA
Self-employed entrepreneur in investor relations since 2006
Deutsche Börse qualified Supervisory Board member since 2017
Member of the Supervisory Board of LEHNER INVESTMENTS AG
Head of Corporate Communications at Siemens London for five years
Head of IR at various listed companies in the software and IT industry for six years
Extensive IPO experience

T: +49 89 125 09 03 33

Sara Pinto

"My motto is 'Create value through communication'. My international professional background helps me to achieve this. I work with clients to get them the best results."

As ESG analyst and investor relations expert and member of the Cross Alliance team, Sara Pinto places particular emphasis on providing her clients with in-depth consultations and on strategic communication. Her specialist area is sustainability.

Head of ESG and Director, since 2019 Consultant at CROSS ALLIANCE
EFFAS Certified ESG Analyst / MA in Business Administration & Management
Five years as Market Research Manager at FOCUS-MONEY
Extensive experience in B2B sales
Expert in CSR and ESG – contact person for sustainability strategy development, implementation of ESG criteria in corporate communications, and sustainability reporting
Language proficiency: Italian (mother tongue), German, English, Spanish

T: +49 89 125 09 03 35

Sven Pauly

"I develop innovative concepts for our clients, which actively contributes to their success."

With many years of experience in TV news production, Sven Pauly specializes in reporting, rule communication of listed companies as well as in the areas of equity/debt investor relations and dual/multiple listings.

Head of Financial Reporting and Director, with CROSS ALLIANCE since 2016.
MA in Corporate Communications/PR
Consultant for investor relations and corporate communications
Extensive experience in capital market consultation
Has held roles in designated sponsoring and public affairs
Over ten years of experience in TV news production

T: +49 89 125 09 03 31